Ngm Biopharmaceuticals Inc

NASDAQ:NGM   3:59:58 PM EDT
13.83
+0.29 (+2.14%)
Earnings Announcements

NGM Reports First Quarter 2022 Financial Results

Published: 05/05/2022 21:38 GMT
Ngm Biopharmaceuticals Inc (NGM) - Ngm Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results.
Ngm Biopharmaceuticals - Qtrly Loss per Share $0.42.
Cash, Cash Equivalents and Short-term Marketable Securities Were $329.8 Million As of March 31, 2022.
Q1 Earnings per Share View $-0.46 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $14.58 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $18.58 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.